Starpharma (ASX:SPL) launches VivaGel in Europe

16Jun

Starpharma (ASX:SPL) launches VivaGel in Europe

 

Starpharma (ASX:SPL) today announced that VivaGel BV has been launched in Central and Eastern European region. 

This launch follows European launches in Germany, UK and several other European countries. 

VivaGel BV is available Over-The-Counter in the region, without the need to see a doctor or obtain a prescription.

The region gives access to more than 45 million women and Mundipharma continues to rollout the product in the region.

VivaGel BV is a novel, non-antibiotic therapy for the treatment of bacterial vaginosis (BV) and prevention of recurrent BV.

Shares in Starpharma (ASX:SPL) are trading 6.7 per cent higher at $1.03.
 
Copyright 2020 – Finance News Network


Source: Finance News Network

Share this post

Related Posts

30Jun

Stocks of the Hour: Blue Star Helium, Magnis Energy Technologies, Downer EDI

30 Jun 2023 - A snapshot of the stocks on the move, featuring Stocks of the Hour: Blue Star Helium, Magnis Energy Technologies and Downer EDI.

Read More
08Jul

WiseTech Global (ASX:WTC) has completed earnout renegotiations

08 Jul 2020 - WiseTech Global (ASX:WTC) today confirmed completion of the remaining earnout renegotiations removing $33.3 million of future contingent cash liabilities owed to multiple acquisition targets.

Read More
11Sep

Sundance Energy to list in the US

1 Sep 2019 - Sundance Energy Australia (ASX:SEA) has decided to re-domicile from Australia to the United States via a proposed Scheme of Arrangement which is subject to shareholder, judicial and regulatory approvals.

Read More
19Jun

Stocks of the Hour: Lake Resources, Bastion Minerals, Dateline Resources

19 Jun 2023 - A snapshot of the stocks on the move featuring Lake Resources (ASX:LKE), Bastion Minerals (ASX:BMO) and Dateline Resources (ASX:DTR).

Read More
20Jan

G Medical Innovations (ASX:GMV) secured Taiwan FDA approval

20 Jan 2020 - Medical product provider, G Medical Innovations (ASX:GMV) has secured regulatory approval from the Taiwan Food and Drug Administration for its Prizma device.

Read More
14Mar

Elixir Energy (ASX:EXR) struggles as Mongolia coal seam gas exploration continues

12 Mar 2021 - Gas exploration player, Elixir Energy (ASX:EXR) has reported a net loss after tax of over $990,000 for the half year ended 31 December 2020.

Read More
18Feb

Santos (ASX:STO) reports 60% fall in NPAT for full year 2020

18 Feb 2021 - Gas supplier Santos (ASX:STO) reports underlying net profit after tax fell 60% to US$287 million for their full year 2020, down US$432 million than 2019.

Read More
11Feb

AGL Energy (ASX:AGL) reports net loss of 808% 1H FY2020

11 Feb 2021 - AGL Energy (ASX:AGL) reports a net loss of $2.28 billion dollars for the first half of the financial year 2020, that’s down 808% on the prior corresponding period.

Read More
01Mar

Stocks of the Hour: Argent Minerals, Valor Resources, Oceana Lithium

01 Mar 2023 - A snapshot of the stocks on the move featuring Argent Minerals (ASX:ARD), Valor Resources (ASX:VAL) and Oceana Lithium (ASX:OCN).

Read More
27Mar

Syrah Resources (ASX:SYR) suspend production at Balama Graphite Operation

27 Mar 2020 - Syrah Resources (ASX:SYR) says The Government of Mozambique has enacted additional measures in relation to the management of COVID-19, including suspension of all inbound travel visa operations and mandating 14-day selfquarantine for all international arrivals.

Read More